Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2004

View Archived Issues

Genmab highlights first quarter progress

Xenova make considerable progress during first quarter

GenVec focuses on progressing TNFerade into later stage clinical trials

Montelukast sodium may improve sleep disordered breathing in children

Update on the pharmacokinetics and effects of ciclesonide in asthma

Clinical response achieved with clofarabine in pediatric acute leukemia

Perifosine reported well tolerated in advanced cancer patients

Novel protein-tyrosine-phosphatase 1B inhibitor improves glucose homeostasis in vivo

Novel PPARgamma activator ameliorates insulin resistance via elevated adiponectin levels

Pharmacokinetics of new polyenemacrolide antifungal agent in rats

Novel DPP-IV inhibitor improves glucose tolerance but does not affect diabetes progression

Paired biopsy study shows normal bone formation after five years of risedronate

Orphan drug designation for Thymosin beta4 for epidermolysis bullosa

Canadian approval of Aldurazyme for MPS I

Proof-of-concept study begins for HCV-086

Phase II alfimeprase study in venous catheter occlusion completes interim analysis

Sativex produces positive results in phase II rheumatoid arthritis study

Isis to acquire Elan's interest in Orasense and HepaSense joint ventures

Promising phase II results for MDX-060 in Hodgkin's disease

Orphan drug status for MDX-101

Positive results for ATL-1102 for multiple sclerosis

Adenovirus vector VRX-011 has enhanced specific oncolytic efficacy and restriction in primary cells

Liraglutide reduces body weight in preclinical and clinical studies

Axokine benefits overweight, diabetic patients

GSK team describes new prostanoid EP1 modulators for pain and other disorders

New antibacterial and antifungal agents identified at GeneSoft

Novel Raf kinase inhibitors in early development at Merck KGaA

Merck Frosst describes a novel series of NO-releasing COX-2 inhibitors

Pfizer claims new ziprasidone derivatives and their use as antipsychotics

Triazole-based vasopressin V1a antagonists and their use in dysmenorrhea therapy

New nuclear hormone receptor ligands covered by Karo Bio patent

New glucocorticosteroids prepared and tested at GSK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...